To evaluate the relationships between to that in NT without BP-E. Supine plasma NE level at entry period and year 10 in NT with BP-E sympathetic nerve activity, insulin sensitivity, and blood pressure ( BP ) elevation, we examined BP, was significantly greater than that in subjects without BP-E ( P õ .05, P õ .01, respectively ) . fasting blood glucose, plasma insulin, and norepinephrine ( NE ) levels in age-and body Supine NE in BHT regardless of BP-E was significantly greater than that in NT at both entry mass index ( BMI ) -matched 662 normotensive ( NT ) and 188 borderline hypertensive ( BHT ) and year 10. These results demonstrate that sympathetic nerve hyperactivity appears to subjects every year for 10 years. All measurements were taken in the supine position after an precede hyperinsulinemia and resultant BP elevation in a young, nonobese Japanese overnight fast. BP elevation ( BP-E ) during 10 years was defined as 10% or more elevation of population. ᭧ 1997 American Journal of Hypertension, Ltd. Am J Hypertens Am J mean BP when compared with BP at entry. BP-E was noted in 186 ( 28% ) of NT and in 52 ( 28% ) of Hypertens 1997; 10:77 -83 BHT. Fasting insulin level at entry in BHT with BP-E was significantly greater than that in KEY WORDS: Sympathetic nerve activity, insulin sensitivity, blood pressure elevation, subjects without BP-E ( P õ .01 ) , although fasting insulin level in NT with BP-E at entry was similar normotension, borderline hypertension, Japanese.
sign. Thus, investigations into the relationship be-Hg, respectively. The mean age and BMI were strictly matched in the three groups at entry ( age: 39.0 { 2.1, tween sympathetic nervous system activity and the insulin-resistant state or hyperinsulinemia in hyper-39.4 { 1.9, 39.4 { 2.0 years, F Å 0.7132, P Å .4906; BMI:
22.4 { 1.2, 22.6 { 1.1, 22.8 { 1.3 kg /m 2 , F Å 0.5000, P tensive patients tend to leave the ''chicken-and-egg'' question open, and, despite tremendous efforts, re-Å .6069, respectively ) , and at year 10 ( age: 49.0 { 2.1, 49.4 { 1.9, 49.4 { 2.0 years, F Å 0.6041, P Å .5678; BMI: sults have not yet been consistent. 16 -20 Furthermore, family history of hypertension and racial differences 22.3 { 1.4, 22.6 { 1.0, 22.7 { 1.5 kg /m 2 , F Å 0.7912, P Å .4679, respectively ) . are also known as confounding factors for insulinresistant states associated with hypertension. 6, 21 -26 A positive family history of hypertension or diabetes mellitus was defined as at least one parent having hyThe goal of the present longitudinal study was to clarify the problem regarding the relationship between pertension or diabetes as documented by previous medical records or by a direct measurement of BP or blood pressure ( BP ) elevation, sympathetic nervous system activity, and insulin sensitivity; in other words, HbA 1c in the parents where possible. Studies were approved by the Ethics Committee of Osaka University to elucidate which comes first: sympathetic nervous system hyperactivity or hyperinsulinemia. We exam-Medical School, and informed consent was obtained from each subject. ined, the levels of NE and insulin between age-and body mass index ( BMI ) -matched normotensive sub-Measurements After an overnight fast of more than jects ( NT ) with and without BP elevation during the 10 12 h, BMI, BP, pulse rate, and venous blood sampling years and, similarly, between borderline hypertensive for measurements of blood glucose levels, plasma insupatients ( BHT ) with and without BP elevations.
lin, and NE levels, triglyceride ( TG ) , total cholesterol ( Tch ) , HDL-ch, VLDL-ch, LDL-ch, uric acid ( UA ) , and SUBJECTS AND METHODS hematocrit ( Ht ) were obtained after a rest of 30 min in Subjects A cohort consisting of 1,568 young Japanese the supine position in a quiet room. BP was measured men working in a factory in Osaka, Japan, was studied more than three times in each visit and was averaged. during a biannual legal health check-up for 10 years. Those who had a wide variability in BP were asked to According to BP status, the cohort was divided into repeat measurements on more than three separate visthree groups: namely, 1,064 normotensive ( NT ) , 283 its, to exclude chance variation. borderline hypertensive ( BHT ) , and 221 established Blood pressures and pulse rates were measured with hypertensive ( EHT ) subjects. The following subjects an automated sphygmomanometer ( TM-2711 or TMwere excluded from the study: 86 subjects who had 2713, A & D, Tokyo, Japan ) which was standardized obesity ( BMI ¢ 26.0 kg /m 2 ) , 43 subjects with diabetes against a mercury sphygmomanometer. Plasma NE mellitus ( HbA 1c ú 6.0% ) , 101 subjects with a positive was measured after separation by high performance family history of diabetes ( at least one parent had dia-liquid chromatography by the fluorometric method 27 betes ) , 58 subjects with severe heart disease ( CTR ú ( intraassay CV Å 2.1%; interassay CV Å 3.6%; sensitiv-52% ) or arrhythmia. Also excluded were 379 subjects ity Å 0.010 to 20 ng /mL ) , and plasma immunoreactive on medications other than antihypertensive drugs: lipid insulin was measured by a standard radioimmunoaslowering agents, 264; uric acid lowering agents, 93; say method ( insulin RIABEAD II, Dinabott, Tokyo, Jamedications for liver dysfunction, 72; digitalis or antiar-pan: intraassay CV Å 1.9%; interassay CV Å 2.2%; sensirythmic agents, 58. Consequently, strictly age-and tivity Å 0.75 to 300 mU/mL). Blood glucose and lipid BMI -matched subjects ( 662 NT, 188 BHT, and 136 fractions were measured by autoanalyzer ( Hitachi-EHT ) were enrolled in this study. BHT were untreated, 7050, Tokyo, Japan ) . and EHT were untreated or stopped their medications for HT at least 2 weeks prior to the measurements each Statistical Analyses Values are shown as mean { SD.
Changes in variables within each group and differyear. Those who had significant change in BMI 1.0 kg / m 2 or greater ( 2 subjects ) , and an additional 31 partici-ences among groups were examined by two-way analysis of variance ( ANOVA ) . And when signifipants were excluded, because of loss of information on plasma insulin or norepinephrine, BP, body habitus, or cant, Dunnett's test was used to determine whether the differences of the mean at year 10 from the values occupational change.
Normotension was defined as supine mean reading at entry period, and those among the groups were significant. The statistical analyses regarding the of less than 140 / 90 mm Hg. Borderline hypertension and established hypertension were defined as mean prevalence of BP elevations or a positive family history of hypertension were performed using the x 2 -reading of 140 to 159 / 90 to 94 mm Hg and 160 / 95 mm Hg or more at entry period, respectively. The hyperten-test. Values of P õ .05 were considered significant. sive patients were in stage I or II of the World Health RESULTS Organization classification. The average BP readings of NT, BHT, and EHT at entry were 122 { 8/73 { 4 mm Table 1 by the definition, BP levels in NT and BHT with BP elevation were significantly greater than those in subjects without BP elevation ( NT: P õ .001, BHT: P õ change in mean BP. BP elevation was defined as 10%
.001 ) , and BP levels in subjects ( NT and BHT ) with or more elevation in mean BP compared with BP lev-BP elevation were significantly greater than those at els at entry period; no change in BP as between /10% entry period ( NT: P õ .01, BHT: P õ .01 ) . At entry and 010%; and BP reduction as 010% or more reduction in mean BP. The prevalence of BP elevation dur-period, systolic ( P õ .01 ) and diastolic BPs ( P õ .01 ) in NT with BP elevation were significantly greater the unbiased fasting insulin and supine NE levels from the effects of age and BMI. Plasma NE levels at than those in NT without BP elevation, but BPs in BHT with BP elevation were similar to those in BHT entry and at year 10 in NT and BHT with BP elevation were significantly greater than those in subjects withwithout BP elevation ( NS ) . Age and BMI in 4 groups according to BP status at entry and BP elevations dur-out BP elevation ( entry period, NT: P õ .05, BHT: P õ .05; year 10, NT: P õ .01, BHT: P õ .05 ) . Furthermore, ing the 10 years were similar to each other. BMI in NT at year 10 did not differ from those at entry, and fasting INS levels in BHT with BP elevation were significantly greater than those in subjects without BP so were the BMI in BHT. Figure 2 shows fasting blood glucose levels ( upper elevation at both entry period ( P õ .01 ) and year 10 ( P õ .05 ) , while fasting INS at entry in NT with BP panel ) , fasting plasma insulin ( middle panel ) and NE levels ( bottom panel ) in NT ( left column ) and BHT elevation was similar to that in NT without BP elevation and that in NT with BP elevation at year 10 were ( right column ) subdivided by the presence or absence of significant BP elevation. In this way, age and BMI significantly greater than that in NT without BP elevation ( P õ .05 ) . were strictly matched at entry, in order to compare
The absolute increment ( left panel ) in plasma insulin and NE during the 10 years and the percentile changes ( right panel ) in plasma insulin and NE are shown in Figure 3 . The absolute increment in plasma NE in NT with BP elevation was significantly greater than that in NT without BP elevation ( P õ .01 ) . Furthermore, the absolute increment in NE in NT with BP elevation was similar to those in BHT regardless of BP elevation, as were the percentile increment in plasma NE in NT with BP elevation. On the other hand, the absolute increment in plasma insulin level in NT with BP elevation and in BHT with BP elevation was significantly greater than those in subjects without BP elevation ( P õ .01, P õ .05, respectively ) and the absolute increment in plasma insulin in BHT without BP elevation was also greater than that in NT without BP elevation ( P õ .05 ) . However, the percent increment in plasma insulin in NT with BP elevation was significantly greater than that in NT without BP elevation, although the percent increments between BHT with and without BP elevation were similar to each other and similar to the values in NT without BP elevation, and were significantly less than that in NT with BP elevation.
DISCUSSION
The main finding from the present study is that supine plasma NE at entry in NT with BP elevation during a period of 10 years was significantly greater than that in NT without BP elevation, although fasting plasma insulin at entry in NT with BP elevation was similar to that in NT without BP elevation. In addition, in BHT with BP elevation, both plasma NE and fasting insulin were significantly greater than those in BHT without BP elevation; and in BHT regardless of BP elevation, fasting blood glucose levels, plasma NE, those in NT without BP elevation, but they were simi-hyperkinetic stage. 9 -11,14,32 -34 Julius et al 14 reported that, as hypertension advances with underlying helar to those in BHT regardless of BP elevation. On the other hand, the absolute and percent increments in modynamic change, sympathetic overactivity becomes less evident; and they believed that this return plasma insulin in subjects ( both NT and BHT ) with BP elevation were greater than those in subjects with-of plasma NE towards normal values reflects the evolving increase of vascular reactivity in hypertenout BP elevation. These results also indicate that the relationship between sympathetic nerve activity and sion. In addition, it has been reported that plasma catecholamine levels 33, 34 and NE spillover rates 32 were insulin sensitivity might be different between NT and BHT, and between the subjects with and without BP increased only in young hypertensive patients. Julius et al 35 also reported that the neurogenic, hyperkinetic elevation during the 10 years.
In addition to many clinical studies 1 -8,20 -26,28 and state could be a secondary consequence of hypertension, because hypertension in its early phase is freepidemiological studies 15,16,29,30 demonstrating a close relationship between insulin resistance and BP eleva-quently associated with a considerable decrease in the intravascular blood volume, which could trigger a tion, Denker et al 31 also reported a significant positive association between fasting insulin and BP levels. secondary sympathetic adjustment. However, in the present study, hematocrit levels considered as an inThere is also general acceptance that both increased insulin and increased sympathetic nervous system ac-dex of intravascular blood volume, were similar between subjects with and without BP elevation in both tivity are involved in hypertension, but which comes first has not yet been clearly demonstrated. It has been NT and BHT ( data not shown ) .
In the present study, plasma NE was greater in young well documented that the degree of sympathetic nervous system activity might vary depending on the BHT than in young NT, and it was significantly greater in subjects with BP elevation compared to that in substage of hypertension: for example, increased sympathetic activity is particularly prominent in the earlier jects without BP elevation. This result is in a good accor- with BP levels only in NT, but not in hypertensives. data from the present study indicated at least that the sympathetic nerve hyperactivity is related to BP lute and percent increments in plasma insulin were significantly greater in subjects with BP elevation than ever, their study was cross-sectional in nature and 13. Tuck ML: Obesity, the sympathetic nervous system and hence could not determine the temporal order of essential hypertension. Hypertension 1992; 19 ( suppl events, particularly whether an increase in insulin
